These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15778110)

  • 1. Economic impact of HIV.
    Veenstra N; Whiteside A
    Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):197-210. PubMed ID: 15778110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macroeconomic and household-level impacts of HIV/AIDS in Botswana.
    Jefferis K; Kinghorn A; Siphambe H; Thurlow J
    AIDS; 2008 Jul; 22 Suppl 1():S113-9. PubMed ID: 18664942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining prevention, treatment and care: lessons from South Africa.
    Achmat Z; Simcock J
    AIDS; 2007 Jul; 21 Suppl 4():S11-20. PubMed ID: 17620746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic impact of delaying or preventing AIDS in persons with HIV.
    Pinkerton SD; Holtgrave DR
    Am J Manag Care; 1999 Mar; 5(3):289-98. PubMed ID: 10351025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macroeconomic impact of HIV: the need for better modelling.
    Lamontagne E; Haacker M; Ventelou B; Greener R
    Curr Opin HIV AIDS; 2010 May; 5(3):249-54. PubMed ID: 20539082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda.
    Marseille E; Saba J; Muyingo S; Kahn JG
    AIDS; 2006 Apr; 20(6):907-14. PubMed ID: 16549976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between economic evaluations and HIV and AIDS treatment policies.
    Taleski SJ; Ahmed K; Whiteside A
    Curr Opin HIV AIDS; 2010 May; 5(3):204-9. PubMed ID: 20539075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs associated with combination antiretroviral therapy in HIV-infected patients.
    Yazdanpanah Y
    J Antimicrob Chemother; 2004 Apr; 53(4):558-61. PubMed ID: 14985277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustaining treatment costs: who will pay?
    Zewdie D; De Cock K; Piot P
    AIDS; 2007 Jul; 21 Suppl 4():S1-4. PubMed ID: 17620744
    [No Abstract]   [Full Text] [Related]  

  • 10. The economics of effective AIDS treatment in Thailand.
    Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
    AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Economic burden and clinical course of HIV infection and AIDS today: how the variation of natural history, available treatments, and strictly related costs play a role in needs of health care].
    Manfredi R; Calza L; Gramegna A; Bocchi F; Fiacchi P; Corsini D; Chiodo F
    Recenti Prog Med; 2001 Nov; 92(11):648-54. PubMed ID: 11765655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acquired immunodeficiency syndrome.
    Russell S
    Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):147-55. PubMed ID: 15331831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.
    Quentin W; König HH; Schmidt JO; Kalk A
    Trop Med Int Health; 2008 Oct; 13(10):1245-56. PubMed ID: 18721185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of socioeconomic impact assessments of HIV/AIDS.
    Forsythe S; Rau B
    AIDS; 1998; 12 Suppl 2():S47-55. PubMed ID: 9792361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic impacts of HIV/AIDS on households and economies.
    ; Marlink R; Forsythe S; Bertozzi SM; Muirhead D; Holmes M; Sturchio J
    AIDS; 2008 Jul; 22 Suppl 1():S87-8. PubMed ID: 18664959
    [No Abstract]   [Full Text] [Related]  

  • 16. The private sector and HIV/AIDS in Africa: taking stock of 6 years of applied research.
    Rosen S; Feeley F; Connelly P; Simon J
    AIDS; 2007 Jul; 21 Suppl 3():S41-51. PubMed ID: 17666961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The (political) economics of antiretroviral treatment in developing countries.
    Nattrass NJ
    Trends Microbiol; 2008 Dec; 16(12):574-9. PubMed ID: 18964022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HIV/AIDS on Gross Domestic Product (GDP) in the WHO Africa Region.
    Kirigia JM; Sambo LG; Okorosobo T; Mwabu GM
    Afr J Health Sci; 2002; 9(1-2):27-39. PubMed ID: 17298143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS is your business.
    Rosen S; Simon J; Vincent JR; MacLeod W; Fox M; Thea DM
    Harv Bus Rev; 2003 Feb; 81(2):80-7, 125. PubMed ID: 12577655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries.
    Orsi F; d'almeida C
    Curr Opin HIV AIDS; 2010 May; 5(3):237-41. PubMed ID: 20539080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.